Skip to main content

Advertisement

SpringerLink
Log in

Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis

  • Review
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

It is controversial whether there is a different risk of recurrence between two histological subtypes in craniopharyngioma (CP) patients. Some reported that adamantinomatous craniopharyngioma (ACP) had a higher risk of recurrence than papillary craniopharyngioma (PCP), but others reported that there is no significant difference between them. So, we conducted this systematic review and meta-analysis to determine the association between the histological subtype of CP and the rate of recurrence. A comprehensive literature search was undertaken in PubMed, EMBASE, and Web of Science for all English articles published up to November 2020. Recurrence data stratified by ACP and PCP were extracted from studies meeting inclusion criteria. A pooled analysis of the association between the histological subtype of craniopharyngioma and rates of recurrence was performed. Thirteen articles containing 974 patients were included. When stratified by two pathological subtypes, the total recurrence rate of ACP was 26.0% and PCP was 14.1%, which showed ACP associated with a higher risk of tumor recurrence than PCP (odds ratio [OR] = 2.12, 95% confidence interval [CI] = 1.36, 3.30, P = 0.00). This is the first meta-analysis focusing on histological subtypes of CP. PCP associates with a lower risk of recurrence than ACP, indicating that ACP could act as one of recurrence risk factors for CP patients. Nevertheless, large sample size and well-designed multicenter studies in which the other clinical variables are controlled to determine the histological subtype of CP as an independent recurrence risk factor are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in the submitted article.

Code availability

Not applicable.

References

  1. Adamson TE, Wiestler OD, Kleihues P, Yaşargil MG (1990) Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 73:12–17. https://doi.org/10.3171/jns.1990.73.1.0012

    Article  CAS  PubMed  Google Scholar 

  2. Bal E, Oge K, Berker M (2016) Endoscopic endonasal transsphenoidal surgery, a reliable method for treating primary and recurrent/residual craniopharyngiomas: nine years of experience. World Neurosurg 94:375–385. https://doi.org/10.1016/j.wneu.2016.07.004

    Article  PubMed  Google Scholar 

  3. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64:401–406. https://doi.org/10.1016/j.jclinepi.2010.07.015

    Article  PubMed  Google Scholar 

  4. Barbosa AP, Varela A, Carvalho D, Cerejo A, Pereira J, Castro L, Vinha E, Monteiro M, Cruz J, Vaz R, Medina JL (2002) Craniopharyngiomas. Clinicopathological aspects in different age groups (Craniofaringeomas. Aspectos clinicopatologicos em diferentes grupos etairios.). Acta Med Port 15:123–129

    CAS  PubMed  Google Scholar 

  5. Bishokarma S, Shrestha S, Ranabhat K, Koirala S, Shrestha D, Panth R, Gongal ND (2018) Outcome of surgical resection of craniopharyngioma: single center 12 years’ experience. Kathmandu Univ Med J 16:328–332

    Google Scholar 

  6. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:547–551. https://doi.org/10.3171/jns.1998.89.4.0547

    Article  CAS  PubMed  Google Scholar 

  7. Burghaus S, Hölsken A, Buchfelder M, Fahlbusch R, Riederer BM, Hans V, Blümcke I, Buslei R (2010) A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas. Virchows Arch 456:287–300. https://doi.org/10.1007/s00428-009-0873-0

    Article  PubMed  Google Scholar 

  8. Capatina C, Vintila M, Gherlan I, Dumitraşcu A, Caragheorgheopol A, Procopiuc C, Ciubotaru V, Poiana C (2018) Craniopharyngioma - clinical and therapeutic outcome data in a mixed cohort of adult and paediatric cases. Acta Endocrinol (Buchar) 14:549–555. https://doi.org/10.4183/aeb.2018.549

    Article  CAS  Google Scholar 

  9. Cavallo L, Frank G, Cappabianca P, Solari D, Mazzatenta D, Villa A, Zoli M, D’Enza A, Esposito F, Pasquini E (2014) The endoscopic endonasal approach for the management of craniopharyngiomas: a series of 103 patients. J Neurosurg 121:100–113. https://doi.org/10.3171/2014.3.Jns131521

    Article  PubMed  Google Scholar 

  10. Cheng J, Shao Q, Pan Z, You J (2016) Analysis and long-term follow-up of the surgical treatment of children with craniopharyngioma. J Craniofac Surg 27(8):e763–e766

    Article  PubMed  Google Scholar 

  11. Clark AJ, Cage TA, Aranda D, Parsa AT, Sun PP, Auguste KI, Gupta N (2013) A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma. Childs Nerv Syst 29:231–238. https://doi.org/10.1007/s00381-012-1926-2

    Article  PubMed  Google Scholar 

  12. Coury J, Davis B, Koumas C, Manzano G, Dehdashti A (2020) Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review. Neurosurg Rev 43:41–48. https://doi.org/10.1007/s10143-018-0978-5

    Article  PubMed  Google Scholar 

  13. Crotty TB, Scheithauer BW, Young WF Jr, Davis DH, Shaw EG, Miller GM, Burger PC (1995) Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 83:206–214. https://doi.org/10.3171/jns.1995.83.2.0206

    Article  CAS  PubMed  Google Scholar 

  14. Dandurand C, Sepehry AA, Asadi Lari MH, Akagami R, Gooderham P (2018) Adult craniopharyngioma: case series, systematic review, and meta-analysis. Neurosurgery 83:631–641. https://doi.org/10.1093/neuros/nyx570

    Article  PubMed  Google Scholar 

  15. de Divitiis E, Cappabianca P, Cavallo LM, Esposito F, de Divitiis O, Messina A (2007) Extended endoscopic transsphenoidal approach for extrasellar craniopharyngiomas. Neurosurgery 61(5 Suppl 2):219–227. https://doi.org/10.1227/01.neu.0000303220.55393.73 (discussion 228)

    Article  PubMed  Google Scholar 

  16. Dho Y, Kim Y, Se Y, Han D, Kim J, Park C, Wang K, Kim D (2018) Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor. J Neurosurg 129:611–619. https://doi.org/10.3171/2017.4.Jns162143

    Article  PubMed  Google Scholar 

  17. Duff J, Meyer FB, Ilstrup DM, Laws ER Jr, Schleck CD, Scheithauer BW (2000) Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery 46(2):291–302. https://doi.org/10.1097/00006123-200002000-00007 (discussion 302-295)

    Article  CAS  PubMed  Google Scholar 

  18. Duff JM, Meyer FB, Ilstrup DM, Laws ER, Schleck CD, Scheithauer BW (2000) Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery 46:291–302. https://doi.org/10.1097/00006123-200002000-00007

    Article  CAS  PubMed  Google Scholar 

  19. Duo D, Gasverde S, Benech F, Zenga F, Giordana MT (2003) MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis. Clin Neuropathol 22:229–234

    CAS  PubMed  Google Scholar 

  20. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634. https://doi.org/10.1136/bmj.315.7109.629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. El Beltagy MA, Attia M, Refaat A, Taha H, Awad M, Zaghloul MS, Abdelaziz AM (2017) Different strategies in management of childhood craniopharyngiomas-experience of 114 case. Childs Nerv Syst 33:1836. https://doi.org/10.1007/s00381-017-3557-0

    Article  Google Scholar 

  22. Eldevik OP, Blaivas M, Gabrielsen TO, Hald JK, Chandler WF (1996) Craniopharyngioma: radiologic and histologic findings and recurrence. Am J Neuroradiol 17:1427–1439

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Eldevik OP, Blaivas M, Gabrielsen TO, Hald JK, Chandler WF (1996) Craniopharyngioma: radiologic and histologic findings and recurrence. AJNR Am J Neuroradiol 17:1427–1439

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90:237–250. https://doi.org/10.3171/jns.1999.90.2.0237

    Article  CAS  PubMed  Google Scholar 

  25. Feng Y, Ni M, Wang Y-G, Zhong L-Y (2019) Comparison of neuroendocrine dysfunction in patients with adamantinomatous and papillary craniopharyngiomas. Exp Ther Med 17:51–56. https://doi.org/10.3892/etm.2018.6953

    Article  CAS  PubMed  Google Scholar 

  26. Fischer EG, Welch K, Shillito J Jr, Winston KR, Tarbell NJ (1990) Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy. J Neurosurg 73:534–540. https://doi.org/10.3171/jns.1990.73.4.0534

    Article  CAS  PubMed  Google Scholar 

  27. JA Forbes, EG Ordóñez-Rubiano, HC Tomasiewicz, MA Banu, I Younus, GA Dobri, CD Phillips, A Kacker, B Cisse, VK Anand, TH Schwartz 2018 Endonasal endoscopic transsphenoidal resection of intrinsic third ventricular craniopharyngioma: surgical results. J Neurosurg:1–11. https://doi.org/10.3171/2018.5.Jns18198

  28. Gardner P, Kassam A, Snyderman C, Carrau R, Mintz A, Grahovac S, Stefko S (2008) Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyngiomas: a case series. J Neurosurg 109:6–16. https://doi.org/10.3171/jns/2008/109/7/0006

    Article  PubMed  Google Scholar 

  29. Garnett MR, Puget S, Grill J, Sainte-Rose C (2007) Craniopharyngioma. Orphanet J Rare Dis 2:18. https://doi.org/10.1186/1750-1172-2-18

    Article  PubMed  PubMed Central  Google Scholar 

  30. Guadagno E, de Divitiis O, Solari D, Borrelli G, Bracale UM, Di Somma A, Cappabianca P, Caro DBD, M, (2017) Can recurrences be predicted in craniopharyngiomas? β-Catenin coexisting with stem cells markers and p-ATM in a clinicopathologic study of 45cases. J Exp Clin Cancer Res 36:95. https://doi.org/10.1186/s13046-017-0562-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Gupta DK, Gupta A, Mahapatra AK, Sharma BS, Vaishya S, Sarkar C, Suri V, Suri A, Kale SS, Singh M (2012) A single centre study of 860 cases of craniopharyngiomas over 5 decades: radical or conservative surgical management. Childs Nerv Syst 28:1609. https://doi.org/10.1007/s00381-012-1849-y

    Article  Google Scholar 

  32. Gupta DK, Ojha BK, Sarkar C, Mahapatra AK, Mehta VS (2006) Recurrence in craniopharyngiomas: analysis of clinical and histological features. J Clin Neurosci 13:438–442. https://doi.org/10.1016/j.jocn.2005.05.013

    Article  PubMed  Google Scholar 

  33. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses Bmj 327:557–560. https://doi.org/10.1136/bmj.327.7414.557

    Article  PubMed  Google Scholar 

  34. Iglesias P, Nocete I, Moure Rodríguez MD, Venegas-Moreno E, Ares J, Biagetti B, Rodríguez Berrocal V, Guerrero-Pérez F, Vicente A, Villar-Taibo R, Cordido F, Paja M, Glerean M, González Rivera N, Dios Fuentes E, Blanco C, Alvaréz-Escolá C, Martín T, Webb SM, Bernabéu I, Villabona C, Soto-Moreno A, Gaztambide S, Díez JJ (2020) Craniopharyngioma in the elderly: a multicenter and nation-wide study in Spain. Neuroendocrinology. https://doi.org/10.1159/000512161

    Article  PubMed  Google Scholar 

  35. Iuzzolino P (2001) Craniopharyngioma - histopathology. Rivista. Medica 7:11–13

    Google Scholar 

  36. Jamshidi AO, Beer-Furlan A, Prevedello DM, Sahyouni R, Elzoghby MA, Safain MG, Carrau RL, Jane JA, Laws ER (2018) A modern series of subdiaphragmatic craniopharyngiomas. J Neurosurg 131:526–531. https://doi.org/10.3171/2018.4.Jns172330

    Article  PubMed  Google Scholar 

  37. Jane JA Jr, Laws ER (2006) Craniopharyngioma Pituitary 9:323–326. https://doi.org/10.1007/s11102-006-0413-8

    Article  PubMed  Google Scholar 

  38. Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, Shine B, Turner HE, Wass JA (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62:397–409. https://doi.org/10.1111/j.1365-2265.2005.02231.x

    Article  CAS  Google Scholar 

  39. Karavitaki N, Cudlip S, Adams CB, Wass JA (2006) Craniopharyngiomas. Endocr Rev 27:371–397. https://doi.org/10.1210/er.2006-0002

    Article  PubMed  Google Scholar 

  40. Li Z, Xu J, Huang S, You C (2015) Aberrant membranous expression of β-catenin predicts poor prognosis in patients with craniopharyngioma. Ann Diagn Pathol 19:403–408. https://doi.org/10.1016/j.anndiagpath.2015.10.002

    Article  PubMed  Google Scholar 

  41. Lilia Tena-Suck M, Moreno-Reyes I, Rembao D, Vega R, Moreno-Jimenez S, de Jesus C-L, Fernandez-Plata R, Martinez-Briseno D, Salinas-Lara C (2009) Clinical pathological study of craniopharyngioma. Fifteen years at the National Institute of Neurology and Neurosurgery “Manuel Velasco Suarez.” Gac Med Mex 145:361–368

    Google Scholar 

  42. Liu J, Sevak I, Carmel P, Eloy J (2016) Microscopic versus endoscopic approaches for craniopharyngiomas: choosing the optimal surgical corridor for maximizing extent of resection and complication avoidance using a personalized, tailored approach. Neurosurg Focus 41:E5. https://doi.org/10.3171/2016.9.Focus16284

    Article  PubMed  Google Scholar 

  43. Lopes MBS (2012) Craniopharyngioma and other cystic lesions of the sellar region: histopathological distinctions and clinical outcomes. Endocr Pathol 23:68. https://doi.org/10.1007/s12022-011-9187-2

    Article  Google Scholar 

  44. Lopez-Serna R, Gómez-Amador JL, Barges-Coll J, Nathal-Vera E, Revuelta-Gutiérrez R, Alonso-Vanegas M, Ramos-Peek M, Portocarrero-Ortiz L (2012) Treatment of craniopharyngioma in adults: systematic analysis of a 25-year experience. Arch Med Res 43:347–355. https://doi.org/10.1016/j.arcmed.2012.06.009

    Article  PubMed  Google Scholar 

  45. A Lukas, H Benjamin, AH Robert, E-K Marwan, M Luigi, R Andreas, SW Rolf, C Emanuel 2018 A ten-year follow-up study of treatment outcome of craniopharyngiomas. Swiss Med Wkly 148. https://doi.org/10.4414/smw.2017.14521

  46. Mahapatra AK, Gupta DK, Gupta A, Sarkar C, Suri A, Suri V, Kale S, Sharma BS (2013) Recurrence factors in craniopharyngiomas: study of clinicomorphologic and histopathologic factors. Childs Nerv Syst 29:1737. https://doi.org/10.1007/s00381-013-2261-y

    Article  Google Scholar 

  47. Maira G, Anile C, Rossi GF, Colosimo C (1995) Surgical treatment of craniopharyngiomas: an evaluation of the transsphenoidal and pterional approaches. Neurosurgery 36:715–724. https://doi.org/10.1227/00006123-199504000-00012

    Article  CAS  PubMed  Google Scholar 

  48. Miller DC (1994) Pathology of craniopharyngiomas: clinical import of pathological findings. Pediatr Neurosurg 21(Suppl 1):11–17. https://doi.org/10.1159/000120855

    Article  PubMed  Google Scholar 

  49. Minamida Y, Mikami T, Hashi K, Houkin K (2005) Surgical management of the recurrence and regrowth of craniopharyngiomas. J Neurosurg 103:224–232. https://doi.org/10.3171/jns.2005.103.2.0224

    Article  PubMed  Google Scholar 

  50. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(264–269):w264. https://doi.org/10.7326/0003-4819-151-4-200908180-00135

    Article  Google Scholar 

  51. Mortini P, Losa M, Pozzobon G, Barzaghi R, Riva M, Acerno S, Angius D, Weber G, Chiumello G, Giovanelli M (2011) Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg 114:1350–1359. https://doi.org/10.3171/2010.11.Jns10670

    Article  PubMed  Google Scholar 

  52. Muller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S (2019) Craniopharyngioma Nat Rev Dis Primers 5:75. https://doi.org/10.1038/s41572-019-0125-9

    Article  PubMed  Google Scholar 

  53. Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, Kristensen LO, Astrup J, Jørgensen JO, Bjerre P, Andersen M, Andersen C, Jørgensen J, Lindholm J, Laurberg P (2011) Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol 104:755–763. https://doi.org/10.1007/s11060-011-0540-6

    Article  CAS  PubMed  Google Scholar 

  54. Nishioka H, Nagata Y, Fukuhara N, Yamaguchi-Okada M, Yamada S (2018) Endoscopic endonasal surgery for subdiaphragmatic type craniopharyngiomas. Neurol Med Chir 58:260–265. https://doi.org/10.2176/nmc.oa.2018-0028

    Article  Google Scholar 

  55. J Pan, S-T Qi, Y-J Deng, Y-Q Ding, L Peng, X-Q Li 2002 Expression of proliferating cell nuclear antigen in craniopharyngioma and tumor recurrence. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 22:363–365

  56. Pan J, Qi S, Liu Y, Lu Y, Peng J, Zhang X, Xu Y, Huang G-l, Fan J (2016) Growth patterns of craniopharyngiomas: clinical analysis of 226 patients. J Pediatr Neurosurg 17:418–433. https://doi.org/10.3171/2015.7.Peds14449

    Article  Google Scholar 

  57. Park H, Dho Y, Kim J, Kim J, Park C, Kim Y (2020) Recurrence rate and prognostic factors for the adult craniopharyngiomas in long-term follow-up. World Neurosurg 133:e211–e217. https://doi.org/10.1016/j.wneu.2019.08.209

    Article  PubMed  Google Scholar 

  58. Park HJ, Dho YS, Kim JH, Kim JW, Park CK, Kim YH (2020) Recurrence rate and prognostic factors for the adult craniopharyngiomas in long-term follow-up. World Neurosurg 133:e211–e217. https://doi.org/10.1016/j.wneu.2019.08.209

    Article  PubMed  Google Scholar 

  59. Paulus W, Honegger J, Keyvani K, Fahlbusch R (1999) Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol 97:377–382. https://doi.org/10.1007/s004010051001

    Article  CAS  PubMed  Google Scholar 

  60. Paulus W, Stöckel C, Krauss J, Sörensen N, Roggendorf W (1997) Odontogenic classification of craniopharyngiomas: a clinicopathological study of 54 cases. Histopathology 30:172–176. https://doi.org/10.1046/j.1365-2559.1997.d01-584.x

    Article  CAS  PubMed  Google Scholar 

  61. Pekmezci M, Louie J, Gupta N, Bloomer MM, Tihan T (2010) Clinicopathological characteristics of adamantinomatous and papillary craniopharyngiomas: University of California, San Francisco experience 1985–2005. Neurosurgery 67:1341–1349. https://doi.org/10.1227/NEU.0b013e3181f2b583

    Article  PubMed  Google Scholar 

  62. Petito CK, DeGirolami U, Earle KM (1976) Craniopharyngiomas: a clinical and pathological review. Cancer 37:1944–1952. https://doi.org/10.1002/1097-0142(197604)37:4

    Article  CAS  PubMed  Google Scholar 

  63. Polom K, Marano L, Marrelli D, De Luca R, Roviello G, Savelli V, Tan P, Roviello F (2018) Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer. Br J Surg 105:159–167. https://doi.org/10.1002/bjs.10663

    Article  CAS  PubMed  Google Scholar 

  64. Prieto R, Pascual J (2018) Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview. Pituitary 21:431–442. https://doi.org/10.1007/s11102-018-0890-6

    Article  PubMed  Google Scholar 

  65. Prieto R, Pascual JM, Rosdolsky M, Castro-Dufourny I, Carrasco R, Strauss S, Barrios L (2016) Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors. Neurosurg Focus 41:E13. https://doi.org/10.3171/2016.9.Focus16304

    Article  PubMed  Google Scholar 

  66. Prieto R, Pascual JM, Subhi-Issa I, Jorquera M, Yus M, Martinez R (2013) Predictive factors for craniopharyngioma recurrence: a systematic review and illustrative case report of a rapid recurrence. World Neurosurg 79:733–749. https://doi.org/10.1016/j.wneu.2012.07.033

    Article  PubMed  Google Scholar 

  67. Qi S, Huang G, Pan J, Li J, Zhang X, Fang L, Liu B, Meng W, Zhang Y, Liu X (2010) Involvement of osteopontin as a core protein in craniopharyngioma calcification formation. J Neurooncol 98:21–30. https://doi.org/10.1007/s11060-009-0053-8

    Article  CAS  PubMed  Google Scholar 

  68. Richardson WS, Wilson MC, Nishikawa J, Hayward RS (1995) The well-built clinical question: a key to evidence-based decisions. ACP J Club 123:A12-13

    Article  CAS  PubMed  Google Scholar 

  69. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z

    Article  PubMed  Google Scholar 

  70. Szeifert GT, Sipos L, Horvath M, Sarker MH, Major O, Salomvary B, Czirjak S, Balint K, Slowik F, Kolonics L, Pasztor E (1993) Pathological characteristics of surgically removed craniopharyngiomas: analysis of 131 cases. Acta Neurochir 124:139–143. https://doi.org/10.1007/BF01401137

    Article  CAS  PubMed  Google Scholar 

  71. Tang B, Xiao L, Xie S, Huang G, Wang Z, Zhou D, Zeng E, Hong T (2018) Extended endoscopic endonasal approach for recurrent or residual symptomatic craniopharyngiomas. Clin Neurol Neurosurg 168:38–45. https://doi.org/10.1016/j.clineuro.2018.02.002

    Article  PubMed  Google Scholar 

  72. Tang B, Xie S, Huang G, Wang Z, Yang L, Yang X, Xu S, Zeng E, Hong T (2020) Clinical features and operative technique of transinfundibular craniopharyngioma. J Neurosurg 133:119–128. https://doi.org/10.3171/2019.3.JNS181953

    Article  CAS  Google Scholar 

  73. Tang B, Xie S, Xiao L, Huang G, Wang Z, Yang L, Yang X, Xu S, Chen Y, Ji Y, Zeng E, Hong T (2018) A novel endoscopic classification for craniopharyngioma based on its origin. Sci Rep 8:10215. https://doi.org/10.1038/s41598-018-28282-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Tavangar SM, Larijani B, Mahta A, Hosseini SM, Mehrazine M, Bandarian F (2004) Craniopharyngioma: a clinicopathological study of 141 cases. Endocr Pathol 15:339–344. https://doi.org/10.1385/ep:15:4:339

    Article  PubMed  Google Scholar 

  75. Tena-Suck ML, Salinas-Lara C, Arce-Arellano RI, Rembao-Bojórquez D, Morales-Espinosa D, Sotelo J, Arrieta O (2006) Clinico-pathological and immunohistochemical characteristics associated to recurrence/regrowth of craniopharyngiomas. Clin Neurol Neurosurg 108:661–669. https://doi.org/10.1016/j.clineuro.2006.01.007

    Article  PubMed  Google Scholar 

  76. Torres LFB, Reis JS, Netto MRM, Delle LAB, Sluminsky BG, Faoro LN, Antoniuk A, Ramina R (1999) Craniopharyngiomas: clinical, epidemiological and pathological findings of 25 cases. Arq Neuropsiquiatr 57:255–260. https://doi.org/10.1590/s0004-282x1999000200014

    Article  CAS  PubMed  Google Scholar 

  77. Van Effenterre R, Boch AL (2002) Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg 97:3–11. https://doi.org/10.3171/jns.2002.97.1.0003

    Article  PubMed  Google Scholar 

  78. Weiner HL, Wisoff JH, Rosenberg ME, Kupersmith MJ, Cohen H, Zagzag D, Shiminski-Maher T, Flamm ES, Epstein FJ, Miller DC, Sweet WH, Laws ER Jr, Cirie IS (1994) Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 35:1001–1011

    Article  CAS  PubMed  Google Scholar 

  79. Xu J, You C, Zhou L, Li Q, Zhou P, Chen N (2010) The cell-cycle kinetics of craniopharyngioma and its clinical significance. J Neurooncol 98:71–76. https://doi.org/10.1007/s11060-009-0047-6

    Article  CAS  PubMed  Google Scholar 

  80. Xu J, Zhang S, You C, Wang X, Zhou Q (2006) Microvascular density and vascular endothelial growth factor have little correlation with prognosis of craniopharyngioma. Surg Neurol 66:30–34. https://doi.org/10.1016/j.surneu.2006.05.047

    Article  Google Scholar 

  81. Yalçin N, Akbulut M, Çagli S, Bir F, Demirtaş E (2009) Prognostic significance of the Ki-67 labeling index and p53 protein expression for patient with craniopharyngioma. J Neurol Sci 26:286–291

    Google Scholar 

  82. Yamada S, Fukuhara N, Oyama K, Takeshita A, Takeuchi Y, Ito J, Inoshita N (2010) Surgical outcome in 90 patients with craniopharyngioma: an evaluation of transsphenoidal surgery. World Neurosurg 74:320–330. https://doi.org/10.1016/j.wneu.2010.06.014

    Article  PubMed  Google Scholar 

  83. Yang I, Sughrue ME, Rutkowski MJ, Kaur R, Ivan ME, Aranda D, Barani IJ, Parsa AT (2010) Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus 28:E5. https://doi.org/10.3171/2010.1.Focus09307

    Article  PubMed  Google Scholar 

  84. Yang L, Xie S, Fang C, Zeng E, Tang B, Hong T (2019) Preservation of hypothalamic function with endoscopic endonasal resection of hypothalamus-invaded craniopharyngiomas. World Neurosurg 132:e841–e851. https://doi.org/10.1016/j.wneu.2019.07.225

    Article  PubMed  Google Scholar 

  85. Zacharia BE, Bruce SS, Goldstein H, Malone HR, Neugut AI, Bruce JN (2012) Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program. Neuro Oncol 14:1070–1078. https://doi.org/10.1093/neuonc/nos142

    Article  PubMed  PubMed Central  Google Scholar 

  86. Zdravkovski P, Ilievski B, Janevska V, Jovanovik R, Cvetkovski P, Mirchevski V, Rendevski V, Aliji V, Zdravkovska M, Petrusevska G (2018) Craniopharyngiomas: 20-year-period evaluation study. Virchows Arch 473:s27–s28. https://doi.org/10.1007/s00428-018-2422-1

    Article  Google Scholar 

  87. Zhang YQ, Ma ZY, Wu ZB, Luo SQ, Wang ZC (2008) Radical resection of 202 pediatric craniopharyngiomas with special reference to the surgical approaches and hypothalamic protection. Pediatr Neurosurg 44:435–443. https://doi.org/10.1159/000172965

    Article  CAS  PubMed  Google Scholar 

  88. Zoicas F, Schofl C (2012) Craniopharyngioma in adults Front Endocrinol (Lausanne) 3:46. https://doi.org/10.3389/fendo.2012.00046

    Article  Google Scholar 

  89. Zuccaro G (2005) Radical resection of craniopharyngioma. Childs Nerv Syst 21:679–690. https://doi.org/10.1007/s00381-005-1201-x

    Article  PubMed  Google Scholar 

  90. Zucchini S, Fantini J, Mazzatenta D, Pozzobon G, Partenope C, Pedicelli S, Ubertini G, Parpagnoli M, Genitori L, Menardi R, Driul D, Matarazzo P, Tuli G, Guzzetti C, Iughetti L, Aversa T, Di Mase R, Rutigliano I, Iezzi ML, Cherubini V, Grandone A, Cassio A (2019) Management and treatment outcome of childhoodonset craniopharyngioma (CP) in Italy: multicentre collection of 117 cases. Horm Res Paediatr 91:329. https://doi.org/10.1159/000501868

    Article  Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundation of China, through grant 82060246.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, 17 Yong Wai Zheng Street, Nanchang, China

    Jie Wu, Xiao Wu, You Qing Yang, Han Ding, Le Yang, You Yuan Bao, Lin Zhou, Chen Xing Yang & Tao Hong

Authors
  1. Jie Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiao Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. You Qing Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Han Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Le Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. You Yuan Bao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chen Xing Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tao Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conception and design: Tao Hong.

Collection and assembly of data: Han Ding, Le Yang, You Yuan Bao, Lin Zhou, and Chen Xing Yang.

Data analysis and interpretation: Jie Wu, Xiao Wu, and You Qing Yang.

Manuscript writing: Jie Wu.

Corresponding author

Correspondence to Tao Hong.

Ethics declarations

Ethics approval

Due to the nature of the present study (literature review), no ethical approval was needed.

Consent to participate

Due to the nature of the present study (literature review), no consent to participate was needed.

Consent for publication

Not applicable.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, J., Wu, X., Yang, Y.Q. et al. Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis. Neurosurg Rev 45, 139–150 (2022). https://doi.org/10.1007/s10143-021-01563-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-021-01563-9

Keywords

Search

Navigation